The Life Sciences Report: Featuring investment ideas in biotechnology, pharmaceuticals, medical devices, tools and diagnostics in interviews with industry-sector experts–analysts, money managers and newsletter writers–backed by the latest research summaries, news and company profiles. It's a combination of information and insight investors can't get anywhere else.
Latest Articles
Phase Two Studies Start for Therapy for Chemo-Treated Breast Cancer Patients
Health
Biopharma’s Migraine Phase 3 Trial Results ‘Robust,’ ‘Impressive’
Coverage Initiated on ‘Emerging Antibiotics Growth Story with Multiple Levers for Upside’
Medical Use of Nitric Oxide Expands as Costs Come Down
Health
Cancer Vaccine Developer Expands Its Collaboration with Merck
Health
U.S. Biotech Partner Obtains Marketing Authorization for ADHD Treatment in Taiwan
Why Tiny ITUS’s CAR-T Therapy Could Be a Big Deal in Cancer Treatment
Health
Canadian Biopharma to Outlicense Pain Drug to South Korean Firm
Health
Biopharma’s Positive FDA Meeting Outlines Path Forward for Trial
Coverage Initiated on Firm with Paradigm-Shifting Colonoscopy Device
Health
Regenerative Medicine Finally Gets Some Respect: Reni Benjamin
Health
Do the Math: Ram Selvaraju on the Appeal of Biotechs in Orphan Diseases
Charles Duncan: 2014 Is for Careful Stock Pickers, Not Dart Throwers
Health
Investing in the Best Canadian Biotech Stocks
Health
How to Pick Winning Biotechs Before the Herd
